Treatment of latent tuberculosis infection: back to the beginning

Clin Infect Dis. 2004 Dec 15;39(12):1772-5. doi: 10.1086/425620. Epub 2004 Nov 18.
No abstract available

Publication types

  • Comment
  • Editorial
  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Antitubercular Agents / therapeutic use*
  • Female
  • Humans
  • Male
  • Pyrazinamide / therapeutic use*
  • Rifampin / therapeutic use*
  • Treatment Outcome
  • Tuberculin Test
  • Tuberculosis / drug therapy*

Substances

  • Antitubercular Agents
  • Pyrazinamide
  • Rifampin